Gelteq Limited Ordinary Shares (GELS)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$0.45+3.48%

Last close · 2026-10-16

Latest quarter · ended 2026-03-31

Revenue

$89,296

Net profit

$-1.9M

Net margin

-2,095.3%

Market cap

$4.8M

Forward P/E

0.0

P/B

0.62

Book value

$0.89

EPS (TTM)

$-0.44

52-week high

$2.01

52-week low

$0.39

50-day MA

$0.59

200-day MA

$0.69

Insiders

47.53%

Institutions

1.03%

Fund	Stake
TWO SIGMA SECURITIES, LLC	0.31%
Jane Street Group LLC	0.28%
Wedbush Morgan Securities Inc	0.19%
Morgan Stanley - Brokerage Accounts	0.14%
Citadel Advisors Llc	0.11%
UBS Group AG	0.00%
Private Advisor Group, LLC	0.00%
Two Sigma Investments LLC	0.00%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Gelteq Limited Ordinary Shares — free to start.

Data updated 2026-10-19.